Form 4 for EVER EverQuote, Inc.
Accepted 2024-12-30 00:00:00 ET · period of report 2024-12-26 · accession 0000950170-24-141183 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-12-30 | 2024-12-26 | EVER | Brainard David | CTO | M - OptEx | $8.21 | +29.2K | 130.3K | +29% | +$240.1K |
| DT | 2024-12-30 | 2024-12-26 | EVER | Brainard David | CTO | S - Sale+OE | $19.93 | -29.2K | 116.2K | -20% | -$582.9K |
| DMT | 2024-12-30 | 2024-12-26 | EVER | Brainard David | CTO | M - OptEx | $0.00 | -29.2K | 9,515 | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-12-26 | M | A | 15,186 | $7.10 | 145,460 | D | — | — | (F1) The option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. |
| 2 | Common | Class A Common Stock | 2024-12-26 | M | A | 14,062 | $9.41 | 130,274 | D | — | — | (F1) The option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. |
| 3 | Common | Class A Common Stock | 2024-12-26 | S | D | 29,248 | $19.93 | 116,212 | D | — | — | (F1) The option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.90 to $20.03, inclusive. The reporting person undertakes to provide EverQuote, Inc., any security holder of EverQuote, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. |
| 4 | Derivative | Stock Option (right to buy) | 2024-12-26 | M | D | 2,500 | $0.00 | 6,875 | D | $7.10 · — to 2033-07-23 | 2,500 Class A Common Stock | (F1) The option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. (F4) This option was granted on July 24, 2023. The vesting start date for the shares underlying the option is August 20, 2023 and vesting occurs quarterly over a four-year period from the vesting start date. |
| 5 | Derivative | Stock Option (right to buy) | 2024-12-26 | M | D | 14,062 | $0.00 | 9,375 | D | $9.41 · — to 2032-06-27 | 14,062 Class A Common Stock | (F1) The option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. (F3) This option was granted on June 28, 2022. The shares underlying the Stock Option are scheduled to vest quarterly over four years with the first installment scheduled to vest on August 20, 2022. |
| 6 | Derivative | Stock Option (right to buy) | 2024-12-26 | M | D | 12,686 | $0.00 | 9,515 | D | $7.10 · — to 2033-07-23 | 12,686 Class A Common Stock | (F1) The option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2024. (F5) This option was granted on July 24, 2023. The vesting start date for the shares underlying the option is August 20, 2023 and vesting occurs quarterly over a two-year period from the vesting start date. |